n,n-dimethylarginine has been researched along with cyanopindolol in 1 studies
Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (cyanopindolol) | Trials (cyanopindolol) | Recent Studies (post-2010) (cyanopindolol) |
---|---|---|---|---|---|
2,216 | 228 | 1,221 | 247 | 1 | 11 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, X; Wang, Y | 1 |
1 other study(ies) available for n,n-dimethylarginine and cyanopindolol
Article | Year |
---|---|
Nebivolol ameliorates asymmetric dimethylarginine-induced vascular response in rat aorta via β3 adrenoceptor-mediated mechanism.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Antagonists; Animals; Aorta; Arginine; Butoxamine; Enzyme Inhibitors; In Vitro Techniques; Nebivolol; Nitric Oxide; Nitric Oxide Synthase; Phenylephrine; Pindolol; Rats; Receptors, Adrenergic, beta-3 | 2016 |